My ePortfolio Register   

Development of immunotherapy in China

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.12.16
Views: 810

Prof Yi-Long Wu - Guangdong General Hospital, China

Prof Wu speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about the changing aetiology and incidence of lung cancer in China.

He describes the developments in surgery and chemotherapy in treating lung cancer patients, and outlines how immunotherapy in adjuvant or neo-adjuvant settings may improve outcomes.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence